4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000009
Chief Medical Officer acquired 53,720 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2024-01-03 | Grant or award | +53,720 | 162,434 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2024-01-03 | Grant or award · Stock Option (right to buy) | +161,160 | 161,160 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1704495415.xml…